title: Chronic myeloid leukemia and ankylosing spondylitis.
authors.forename: Kaouther
authors.initials: K
authors.lastname: Ben Abdelghani
authors.forename: Mohamed
authors.initials: M
authors.lastname: El Menaa
authors.forename: Khaoula
authors.initials: K
authors.lastname: Ben Abdelghani
authors.forename: Leila
authors.initials: L
authors.lastname: Souabni
authors.forename: Salwa
authors.initials: S
authors.lastname: Belhadj
authors.forename: Selma
authors.initials: S
authors.lastname: Chekili
authors.forename: Ahmed
authors.initials: A
authors.lastname: Laatar
authors.forename: Leith
authors.initials: L
authors.lastname: Zakraoui
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001549:Benzamides; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D013167:Spondylitis, Ankylosing / Q000175:diagnosis* / Q000628:therapy
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate